-
1دورية أكاديمية
المؤلفون: Brazel, Danielle, Ou, Sai-Hong, Nagasaka, Misako
مصطلحات موضوعية: TIGIT, immunotherapy, small cell lung cancer, tiragolumab
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/4k88j050Test
-
2دورية أكاديمية
المؤلفون: Brazel D, Ou SI, Nagasaka M
المصدر: Lung Cancer: Targets and Therapy, Vol Volume 14, Pp 1-9 (2023)
مصطلحات موضوعية: tiragolumab, tigit, immunotherapy, small cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.dovepress.comTest/tiragolumab-anti-tigit-in-sclc-skyscraper-02-a-towering-inferno-peer-reviewed-fulltext-article-LCTT; https://doaj.org/toc/1179-2728Test
-
3دورية أكاديمية
المؤلفون: Nicolas Roussot, Jean-David Fumet, Emeric Limagne, Marion Thibaudin, Alice Hervieu, Audrey Hennequin, Sylvie Zanetta, Lorraine Dalens, Théo Fourrier, Loick Galland, Pierre Jacob, Aurélie Bertaut, Emilie Rederstorff, Cédric Chevalier, Sarah Ghirardi, Elodie Gilbert, Azzat Khoukaz, Etienne Martin, Constance Nicolet, Magali Quivrin, David Thibouw, Noémie Vulquin, Gilles Truc, Magali Rouffiac, Francois Ghiringhelli, Céline Mirjolet
مصطلحات موضوعية: Medicine, Pharmacology, Immunology, Cancer, Hematology, Virology, Non-small cell lung cancer, Renal cell cancer, Bladder cancer, Head and neck cancer, PDL-1, TIGIT, Atezolizumab, Tiragolumab, Stereotactic body radiation therapy, SBRT, Immunotherapy
الإتاحة: https://doi.org/10.6084/m9.figshare.24540556.v1Test
https://figshare.com/articles/journal_contribution/Additional_file_1_of_A_phase_I_study_of_the_combination_of_atezolizumab_tiragolumab_and_stereotactic_body_radiation_therapy_in_patients_with_metastatic_multiorgan_cancer/24540556Test -
4دورية أكاديمية
المؤلفون: Badhrinarayanan, Shreya, Cotter, Christopher, Zhu, Huaqi, Lin, Ya-Chen, Kudo, Masatoshi, Li, Daneng
المصدر: Future Oncol ; ISSN:1744-8301
مصطلحات موضوعية: Phase III trial, advanced liver cancer, atezolizumab, bevacizumab, hepatocellular carcinoma, overall survival, progression-free survival, safety, tiragolumab, treatment efficacy
العلاقة: https://doi.org/10.1080/14796694.2024.2355863Test; https://pubmed.ncbi.nlm.nih.gov/38861301Test
الإتاحة: https://doi.org/10.1080/14796694.2024.2355863Test
https://pubmed.ncbi.nlm.nih.gov/38861301Test -
5
المؤلفون: Lena Horvath, Andreas Pircher
المصدر: Memo
مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, EGFR, Ipilimumab, Pembrolizumab, 03 medical and health sciences, 0302 clinical medicine, Trastuzumab, Atezolizumab, Internal medicine, medicine, Osimertinib, Trastuzumab deruxtecan, Lung cancer, Chemotherapy, business.industry, Hematology, medicine.disease, Short Review, Tiragolumab, Nivolumab, 030220 oncology & carcinogenesis, business, 030215 immunology, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a27253d2a24b1aaebbb6444965586576Test
http://europepmc.org/articles/PMC7804575Test